CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Given the likelihood of COVID-19 remaining an endemic disease among high-risk populations, establishing effective mitigation interv...
Long Island City, New York, United States and 1 other location
IV compared to remdesivir IV alone for the treatment of symptomatic COVID-19 in severely immunocompromised adult participants who a...
Phase 3
Teaneck, New Jersey, United States of America and 7 other locations
The purpose of this trial is to assess the safety and relative efficacy of CVXGA (CVXGA50), a KP.2 containing vaccine, compared to COMIRNATY® (COVID...
Phase 2
Jersey City, New Jersey, United States and 54 other locations
of the study is to assess the safety and immunogenicity of IIV-HD (high-dose inactivated influenza vaccine) + rC19 (adjuvanted recombinant COVID...
Phase 1, Phase 2
New York, New York, United States and 11 other locations
vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19).In order to represent a more recently circulating SAR...
Phase 2
New York, New York, United States and 144 other locations
seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...
Phase 3
New York, New York, United States and 66 other locations
The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do n...
Phase 3
Bronx, New York, United States and 83 other locations
Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most oft-...
Phase 3
New York, New York, United States and 167 other locations
study treatment works in the study) of the study medicine (called nirmatrelvir/ritonavir) for potential treatment of coronavirus disease 2019 (COVID...
Phase 3
New York, New York, United States and 76 other locations
studies or substudies based on age group and prior history of COVID-19 vaccinations. All participants in each of the 5 sub-studies ...
Phase 2, Phase 3
Brooklyn, New York, United States of America and 114 other locations
Clinical trials
Research sites
Resources
Legal